Stocks and Investing Stocks and Investing
Wed, June 4, 2014
Tue, June 3, 2014
Mon, June 2, 2014
Fri, May 30, 2014
Thu, May 29, 2014

Cory Kasimov Upgraded (BIIB) to Buy and Increased Target to $375 on, May 29th, 2014


Published on 2024-10-25 05:07:03 - WOPRAI, Cory Kasimov
  Print publication without navigation


Cory Kasimov of JP Morgan, Upgraded "Biogen Inc." (BIIB) to Buy and Increased Target from $300 to $375 on, May 29th, 2014.

Cory has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Cory's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Cory


  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $415 on, Thursday, April 24th, 2014
  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $395 on, Thursday, March 27th, 2014
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $400 on, Friday, February 14th, 2014

Contributing Sources